Navigation Links
Sanofi-aventis Announces Second Quarter 2009 Results
Date:7/29/2009

rbesartan generics began to be marketed in the monotherapy segment in Spain and Portugal. In these two countries, as well as in Finland, Norway and some Eastern European countries, irbesartan is not protected by an active ingredient patent. In the main European countries, Aprovel((R)) is protected by an active ingredient patent through August 2012. Net sales of Aprovel((R)) as a monotherapy in European countries with no active ingredient patent were approximately euro 50 million in 2008.

                              Change at          Change at
                               constant           constant
                         Q2    exchange     H1    exchange
     Millions of euros  2009    rates      2009    rates
     ----------------- ------- ---------- ------- ----------
    Europe               250     -0.4%       498     +1.8%
    ------             ------- ---------- ------- ----------

    United States        135     -1.7%       267     -1.3%
    -------------     -------- ---------- ------- ----------

    Other Countries      123     -6.3%       250     +5.1%
    -------------     -------- ---------- ------- ----------

    TOTAL                508     -2.2%     1,015     +1.9%
    -------------     -------- ---------- ------- ----------

Other Pharmaceutical Products

In the United States, second-quarter net sales of the sleep aid Ambien((R)) CR were up 11.5% at euro 128 million. First-half net sales of the product were up 1.1% at euro 257 million. In Japan, net sales of Myslee((R)), the leading hypnotic on the market, rose by 13.1% in the second quarter to euro 49 million, while first-half net sales were 20.3% higher at euro 93 million.

Despite another good performance in Japan (12.2% growth), Allegra((R)) posted a slight drop (of 0.6%) in second-quarter net sales to euro 191 million. First-half
'/>"/>

SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Related biology technology :

1. Sanofi-aventis Announces Settlement of Average Wholesale Price Civil Suits With the U.S. Department of Justice Relating to Anzemet(R)
2. Shareholder Class Action Filed Against Sanofi-Aventis by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
3. Sanofi-aventis SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award
4. ThalesNano Inc. and sanofi-aventis R&D Collaborate on Continuous Process Chemistry in Order to Dramatically Reduce Drug Realization Time
5. RainDance Technologies Signs a Collaboration Agreement with sanofi-aventis and Louis Pasteur University to Launch dScreen Consortium within ALSACE BIOVALLEY cluster
6. AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia
7. BioWa Announces License of POTELLIGENT(R) Technology to sanofi-aventis
8. Sanofi-aventis U.S. to Acquire Oral Chronic Lymphocytic Leukemia Treatment
9. Sanofi-aventis U.S. Announces Settlement of Medicaid Best Price Investigation
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 29, 2014  Discovery Laboratories, Inc. (Nasdaq: DSCO),  ... new standard of respiratory critical care, will report its ... 2014 before the open of the U.S. financial ... a live teleconference and webcast at 9:00 a.m. Eastern ... Discovery Labs, management will discuss the 2014 second ...
(Date:7/29/2014)... A new report by Allied ... and geography) - Size, Share, Global Trends, Company Profiles, ... 2013 - 2020", suggests that the global surgical equipment ... registering a CAGR of 11.1% from 2014 to 2020. ... electro surgical devices in operative procedures by providing highly ...
(Date:7/29/2014)... BEVERLY HILLS, Calif. , July 29, 2014 ... company specializing in personalized medicine, treatment of infectious ... developing strategies of prognosis and prevention of pathologies ...  As of August 1, 2014, ImmunoClin Corporation will ... to Washington, D.C. , a ...
(Date:7/29/2014)... & Rockville, MD (PRWEB) July 29, 2014 ... Inc. (ITI), a vaccine pioneer in the biotechnology ... services firm Newport Coast Securities, Inc. to explore ... is commercializing LAMP-vax technology, a breakthrough vaccine platform ... and immunotherapy market. The company exclusively licensed the ...
Breaking Biology Technology:Discovery Labs to Report 2014 Second Quarter Financial Results and Hold Conference Call on Tuesday, August 5, 2014 at 9:00 a.m. Eastern Time 2Global Surgical Equipment Market is expected to reach $12.1 billion by 2020 - Allied Market Research 2Global Surgical Equipment Market is expected to reach $12.1 billion by 2020 - Allied Market Research 3ImmunoClin Corporation (IMCL) Relocates Corporate Headquarters to Washington, DC 2ImmunoClin Corporation (IMCL) Relocates Corporate Headquarters to Washington, DC 3Immunomic Therapeutics Engages Newport Coast Securities, Inc. 2Immunomic Therapeutics Engages Newport Coast Securities, Inc. 3
... Arbios Systems, Inc.,(OTC Bulletin Board: ABOS) today announced ... in its bioartificial liver system, HepatAssist, to HepaLife,Technologies, ... developing proprietary cell-based medical technologies to improve,protect and ... The terms of the deal included $450,000 in ...
... Patients Describe Their Life-Changing Results, CHAPEL HILL, ... classic "talk therapy" with a dynamic new set ... -- especially with,chronic health conditions such as pain, ... including Post Traumatic Stress Disorder (PTSD).,Known as "Energy ...
... Oct. 7, 2008 Senomyx, Inc.,(Nasdaq: SNMX ... taste,receptor technologies to discover and develop novel flavor ... announced today that,Kent Snyder, the Company,s President and ... and Business Officer, will present a,corporate overview on ...
Cached Biology Technology:Arbios Sells HepatAssist Bioartificial Liver System to HepaLife Technologies, Inc. 2Arbios Sells HepatAssist Bioartificial Liver System to HepaLife Technologies, Inc. 3Upcoming 'Energy Psychology' Event - New Breakthrough 'Do It Yourself' Healing 2SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE WACHOVIA CONSUMER GROWTH CONFERENCE 2
(Date:7/29/2014)... is the first to show that while the impact ... these negative effects may be reduced by maintaining a ... study participants who exercised, slept well and ate well ... maintain healthy lifestyles, even when they had similar levels ... professor in the department of psychiatry at UCSF. "It,s ...
(Date:7/28/2014)... Millions of people in the United States have a ... It can be painful and may even require surgery ... skeletal muscle wasting and, in turn, limb amputation. , ... Houston (UTHealth) Medical School, scientists tested a non-surgical preventative ... it was associated with increased blood circulation. Their ...
(Date:7/28/2014)... pennellii , a wild relative of the domestic tomato, ... including the labs headed by Professors Neelima Sinha and ... Biology. The new genome information may help breeders produce ... 27 in the journal Nature Genetics , was ... in Germany. The UC Davis labs carried out work ...
Breaking Biology News(10 mins):Healthy lifestyle may buffer against stress-related cell aging, study says 2Scientists discover genetic switch that can prevent peripheral vascular disease in mice 2
... published online in the open-access journal PLoS Pathogens, Dr. ... colleagues identify new host species for avian influenza A ... between the ecology and epidemiology of various global strains ... included more than 36,000 wild migratory birds tested for ...
... of Missouri-Columbia has discovered a way to create engineered ... This discovery opens new possibilities for the development of ... bacteria and herbicides, and for the development of proteins ... illnesses. , In a paper published in the Proceedings ...
... genetic adaptations in the nematode Acrobeloides nanus. The ... more eggs under polluted conditions than the worms ... this in her study into the long-term effects ... Environmental pollution is an important cause of stress ...
Cached Biology News:Researchers attach genes to minichromosomes in maize 2Asexual worm quickly adapts to soil contamination 2
XBP-1 (F-4)...
Mouse monoclonal [AE3] to Cytokeratin 1 - 8, prediluted ( Abpromise for all tested applications). Antigen: Tissue / cell preparation - Human epidermal cells. Entrez GeneID: 140807 Swiss P...
pETDuet-1 is designed for the coexpression of two target genes....
...
Biology Products: